SATO VICKI L

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
126
Insider Sells Sum
$22.75M

Insider Activity of SATO VICKI L

According to the SEC Form 4 filings, SATO VICKI L, being in a position of

  1. director at Denali Therapeutics Inc.,
    оver the last 12 months, has bought 0 shares, and sold 22698 shares for $513,572,
    over all time since 2021-03-03, has bought 0 shares, and sold 51020 shares for $1.78M.
  2. director at Vir Biotechnology, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 10960 shares for $137,219,
    over all time since 2021-05-19, has bought 0 shares, and sold 475608 shares for $16.63M.

The largest sale of all time was on 2021-12-20 and amounted to 30348 shares of Vir Biotechnology, Inc. for $1.65M.

Biography of SATO VICKI L

No biography is available at this moment.

2025-01-08SaleVir Biotechnology, Inc.
VIR
director
10,960
0.008%
$12.52$137,219-0.32%
2025-01-02SaleDenali Therapeutics Inc.
DNLI
director
3,080
0.0021%
$20.91$64,403+1.63%
2024-11-07SaleDenali Therapeutics Inc.
DNLI
director
1,020
0.0007%
$30.00$30,600-19.32%
2024-11-01SaleDenali Therapeutics Inc.
DNLI
director
3,080
0.0022%
$27.07$83,376-10.46%
2024-09-13SaleDenali Therapeutics Inc.
DNLI
director
1,020
0.0007%
$30.00$30,600-14.95%
2024-09-03SaleDenali Therapeutics Inc.
DNLI
director
3,080
0.0021%
$25.00$77,007+3.34%
2024-07-01SaleDenali Therapeutics Inc.
DNLI
director
3,080
0.0022%
$22.14$68,2040%
2024-05-15SaleDenali Therapeutics Inc.
DNLI
director
1,674
0.0011%
$20.39$34,133+15.51%
2024-04-15SaleDenali Therapeutics Inc.
DNLI
director
1,666
0.0012%
$18.29$30,471+30.75%
2024-03-15SaleDenali Therapeutics Inc.
DNLI
director
1,666
0.0012%
$20.10$33,487+10.95%
2024-02-15SaleDenali Therapeutics Inc.
DNLI
director
1,666
0.0012%
$18.37$30,604+17.97%
2024-01-16SaleDenali Therapeutics Inc.
DNLI
director
1,666
0.0012%
$18.42$30,688+14.64%
2023-12-15SaleDenali Therapeutics Inc.
DNLI
director
1,666
0.0012%
$23.39$38,968-8.03%
2023-11-15SaleDenali Therapeutics Inc.
DNLI
director
1,666
0.0012%
$19.13$31,871+10.19%
2023-10-16SaleDenali Therapeutics Inc.
DNLI
director
1,666
0.0012%
$20.66$34,420-3.28%
2023-09-15SaleDenali Therapeutics Inc.
DNLI
director
1,666
0.0012%
$23.62$39,348-14.86%
2023-08-15SaleDenali Therapeutics Inc.
DNLI
director
1,666
0.0012%
$24.30$40,484-17.13%
2023-07-17SaleDenali Therapeutics Inc.
DNLI
director
1,666
0.0012%
$29.60$49,314-31.39%
2023-06-30SaleVir Biotechnology, Inc.
VIR
director
18,000
0.0136%
$24.66$443,916-59.52%
2023-06-28SaleDenali Therapeutics Inc.
DNLI
director
1,666
0.0012%
$29.84$49,709-31.79%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.